Build a lasting personal brand

Six Peptide Compounds Dominate 2026 Laboratory Research, Review Finds

By Editorial Staff
CHEAT CODES INC published a ranked review identifying BPC-157, Epithalon, and four other peptides as the most studied compounds in peer-reviewed literature, providing a consolidated reference for preclinical researchers.

Found this article helpful?

Share it with your network and spread the knowledge!

Six Peptide Compounds Dominate 2026 Laboratory Research, Review Finds

A new research review from CHEAT CODES INC has identified the six most studied peptide compounds in peer-reviewed literature as of 2026, offering a consolidated reference for laboratory researchers engaged in preclinical studies. The review, published on the company's website, evaluates BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon based on biochemical profile, citation volume, and documented in vitro or in vivo outcomes.

BPC-157, a 15-amino acid sequence derived from a protective gastric protein, leads the list with over two decades of published animal model studies. Research has documented its effects on tendon-to-bone healing, nitric oxide pathway modulation, and gastrointestinal mucosal integrity. A frequently cited 2019 study in the Journal of Physiology - Paris recorded accelerated Achilles tendon repair in rat models.

TB-500 (Thymosin Beta-4) is a 43-amino acid peptide involved in actin sequestration and cell migration signaling. In vitro studies have identified its role in endothelial cell proliferation and wound closure assays. A 2016 publication in the Annals of the New York Academy of Sciences documented its involvement in cardiac tissue repair pathways following ischemic events in animal models.

CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH) modified with drug affinity complex (DAC) technology, extends plasma half-life. Peer-reviewed pharmacokinetic studies, including a 2006 paper in the Journal of Clinical Endocrinology & Metabolism, documented sustained growth hormone elevation over six days in animal and early-phase human cell studies.

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Its in vitro selectivity profile shows minimal cross-reactivity with cortisol or prolactin pathways, a distinction documented in a 1998 study in the European Journal of Endocrinology. In vivo rat model data has further examined its effects on bone density markers.

Selank, a heptapeptide analogue of the immunomodulatory peptide tuftsin, has been documented in over 30 peer-reviewed studies indexed in international databases as of 2024. Russian Academy of Sciences publications note its effects on GABA-A receptor modulation and enkephalin stabilization in rodent models, with in vitro studies examining its influence on interleukin-6 expression.

Epithalon (Epitalon), a synthetic tetrapeptide derived from the pineal peptide preparation epithalamin, is most cited for telomerase activation in somatic cells. A 2003 study in Neuroendocrinology Letters reported telomere elongation observed in human somatic cell cultures, with additional in vivo findings in aged animal models examining circadian rhythm and melatonin synthesis pathways.

Dr. Marcus Hale, Director of Research Curation at CHEAT CODES INC, said, 'This review covers six peptide compounds with a combined peer-reviewed citation record spanning more than 25 years of published science. The intent is to give laboratory researchers a consolidated reference point grounded entirely in documented in vitro and in vivo data.'

The review drew exclusively from indexed peer-reviewed publications and excluded anecdotal or commercial sources. All six compounds are available for laboratory procurement through Cheat Codes Peptides, which supplies catalogued peptide compounds strictly for research use.

Editorial Staff

Editorial Staff

@editorial-staff

Newswriter.ai is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.